Philips’ strong partnerships across imaging, planning and treatment support increased precision and clinical confidence to help clinicians deliver the best possible care. Demonstrating continued success for Philips’ strategic partnership with IBA, Proton Partners International continues to roll out its network of UK cancer centers incorporating integrated systems from Philips and IBA. In June, Elekta announced that it has received CE marking for Elekta Unity, the world's first high-field MR-linac, which incorporates Philips’ 1.5T digital MR imaging technology.
Earlier this year, Philips announced that it is collaborating with Sun Nuclear to integrate its suite of PlanIQ™ software into Pinnacle. At ASTRO, Philips is announcing that it has signed an agreement with Lifeline Software Inc. to utilize its dose verification technology. Lifeline is a developer of fully automated independent dosimetric validation calculations for conventional, IMRT, and VMAT treatment plans, including utilizing the ‘Monte Carlo’ dose calculation algorithm, widely recognized as the gold standard dose calculation method.
Visit Philips at booth #2111 at ASTRO. For more information about Philips’ presence at the show, including the full suite of Philips radiation oncology technology and integrated solutions, visit Philips’ ASTRO event website and follow @PhilipsLiveFrom for updates throughout #ASTRO18.
 Compared to Philips exams without Compressed SENSE
 The Ingenia Ambition 1.5T contains less than 0.5% of the helium of a conventional system and this is permanently sealed inside the device
 Compared to the Ingenia 1.5T ZBO magnet
 MR-only simulation for pelvis is pending 510(k) approval and not available for sale in the USA